This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wilhelm, M. J. Articles by Tilney, N. L. Search for Related Content PubMed PubMed Citation Articles by Wilhelm, M. J. Articles by Tilney, N. L. Related Collections Animal models of human disease Risk Factors Brain Circulation and Metabolism Growth factors/cytokines

(Circulation. 2000;102:2426.)
© 2000 American Heart Association, Inc.

Basic Science Reports

Activation of the Heart by Donor Brain Death Accelerates Acute Rejection After Transplantation

Markus J. Wilhelm, MD; Johann Pratschke, MD; Francisca Beato, BS; Maarten Taal, MD; Mamoru Kusaka, MD; Wayne W. Hancock, MD, PhD; Nicholas L. Tilney, MD

From the Surgical Research Laboratory, Harvard Medical School and the Department of Surgery, Brigham and Women’s Hospital (M.J.W., J.P., M.K., N.L.T.); the Department of Medicine, Renal Division, Brigham and Women’s Hospital (F.B., M.T.); and Millenium Inc, Cambridge, Mass, and Department of Pathology, Harvard Medical School (W.W.H.), Boston, Mass. Dr Wilhelm is now at the Department of Cardiothoracic Surgery, University of Muenster, Germany.

Correspondence to Nicholas L. Tilney, MD, Surgical Research Laboratory, E-1, Room 142, Harvard Medical School, 260 Longwood Ave, Boston, MA 02115. E-mail bhayslett{at}rics.bwh.harvard.edu

Background—Donor brain death upregulates expression of inflammatory mediators in the heart. It is hypothesized that these nonspecific changes trigger and amplify acute rejection in unmodified recipients compared with hearts from normal living donors. We examined the inflammatory and immunological consequences of gradual-onset donor brain death on cardiac allografts after transplantation.

Methods and Results—Functioning hearts were engrafted from normotensive donors after 6 hours of ventilatory support. Hearts from brain-dead rats (Fisher, F344) were rejected significantly earlier (mean±SD, 9.3±0.6 days) by their (Lewis) recipients than hearts from living donor controls (11.6±0.7 days, P=0.03). The inflammatory response of such organs was accelerated, with rapid expression of cytokines, chemokines, and adhesion molecules and brisk infiltration of associated leukocyte populations. Upregulation of major histocompatibility class II antigens increased organ immunogenicity. Acute rejection evolved in hearts from brain-dead donors more intensely and at a significantly faster rate than in controls.

Conclusions—Donor brain death is deleterious to transplanted hearts. The resultant upregulation of inflammatory factors provokes host immune mechanisms and accelerates the acute rejection process in unmodified hosts.

Key Words: brain • transplantation • inflammation • rejection

This article has been cited by other articles:

				S. Ullah, L. Zabala, B. Watkins, and M. L Schmitz Cardiac organ donor management Perfusion, March 1, 2006; 21(2): 93 - 98. [Abstract] [PDF]

				J. Odim, H. Laks, A. Banerji, K. Mukherjee, C. Vincent, C. Murphy, C. Burch, and D. Gjertson Does duration of donor brain injury affect outcome after orthotopic pediatric heart transplantation? J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 187 - 193. [Abstract] [Full Text] [PDF]

				J. S. Ganesh, C. A. Rogers, N. R. Banner, R. S. Bonser, and on behalf of the Steering Group Donor cause of death and medium-term survival after heart transplantation: A United Kingdom national study J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1153 - 1159. [Abstract] [Full Text] [PDF]

				M. Heydtmann, P. F. Lalor, J. A. Eksteen, S. G. Hubscher, M. Briskin, and D. H. Adams CXC Chemokine Ligand 16 Promotes Integrin-Mediated Adhesion of Liver-Infiltrating Lymphocytes to Cholangiocytes and Hepatocytes within the Inflamed Human Liver J. Immunol., January 15, 2005; 174(2): 1055 - 1062. [Abstract] [Full Text] [PDF]

				J. L. Contreras, C. Eckstein, C. A. Smyth, M. T. Sellers, M. Vilatoba, G. Bilbao, F. G. Rahemtulla, C. J. Young, J. A. Thompson, I. H. Chaudry, et al. Brain Death Significantly Reduces Isolated Pancreatic Islet Yields and Functionality In Vitro and In Vivo After Transplantation in Rats Diabetes, December 1, 2003; 52(12): 2935 - 2942. [Abstract] [Full Text] [PDF]

				G. Vassalli, S. Fleury, J. Li, J.-J. Goy, L. Kappenberger, and L. K. von Segesser Gene transfer of cytoprotective and immunomodulatory molecules for prevention of cardiac allograft rejection Eur. J. Cardiothorac. Surg., November 1, 2003; 24(5): 794 - 806. [Abstract] [Full Text] [PDF]

				G. Plenz, H. Eschert, M. Erren, T. Wichter, M. Bohm, M. Flesch, H. H. Scheld, and M. C. Deng The interleukin-6/interleukin-6-receptorsystem is activated in donor hearts J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1508 - 1512. [Abstract] [Full Text] [PDF]

				S. C. Stoica, M. Goddard, and S. R. Large The endothelium in clinical cardiac transplantation Ann. Thorac. Surg., March 1, 2002; 73(3): 1002 - 1008. [Abstract] [Full Text] [PDF]

				M. Gorlitzer, H. J. Ankersmit, G. Wollenek, W. Wisser, G. Wieselthaler, M. Haisjackl, R. Horvat, H. Gabriel, E. Wolner, and M. Grimm Backtable ventricular and atrial septal defect repair of an Eisenmenger allograft with concomitant domino heart transplantation J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 374 - 376. [Full Text] [PDF]

				J. PRATSCHKE, M. J. WILHELM, I. LASKOWSKI, M. KUSAKA, F. BEATO, S. G. TULLIUS, P. NEUHAUS, W. W. HANCOCK, and N. L. TILNEY Influence of Donor Brain Death on Chronic Rejection of Renal Transplants in Rats J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2474 - 2481. [Abstract] [Full Text] [PDF]